The long-simmering tension between regulatory bodies and the homeopathic industry in Spain has reached a definitive conclusion. The Spanish Agency for Medicines and Health Products (AEMPS) recently released a comprehensive report declaring that homeopathic treatments lack any demonstrated efficacy. The findings represent a significant blow to an industry that has historically generated millions of euros in revenue despite persistent skepticism from the scientific community.
The report is built on a rigorous foundation, synthesizing 64 systematic reviews of scientific studies published since 2009. According to the AEMPS, these products offer no clinical benefit for a wide array of conditions, including depression, autoimmune diseases, and dermatological issues. The agency’s stance reflects a broader movement within European health systems to separate evidence-based medicine from treatments that rely on extreme dilution.
For years, scientists have argued that any perceived improvements reported by patients are the result of three primary factors: the placebo effect, the natural progression of the illness, and the methodological flaws of studies funded by the industry itself. By formalizing these critiques into a national health mandate, Spain is effectively closing the door on the medical legitimacy of homeopathy, signaling a shift toward a more strictly empirical regulatory environment.
With reporting from Xataka.
Source · Xataka
